Appeal No. 95-2603
Application 07/915,871
all the claims remaining in this application.
According to appellants, the invention is concerned with
pharmaceutical compositions comprising bicyclam or related
polyazacyclohexa- or tetra-decanes, active against HIV-
infected cells in vitro (brief, page 1). 2
Claim 23 has been amended by an amendment filed with the
reply brief dated Dec. 28, 1994 (Paper No. 19), and entered as
noted by the examiner in the Supplemental Answer dated Mar.
13, 1995 (Paper No. 20). Claims 23, 7 and 8 are reproduced
below:
23. A pharmaceutical composition which is active
against HIV-infected cells in in vitro tests comprising, as
active ingredient, a compound selected from the group
consisting of bicyclam
3,3'-bis-1,5,9,13-tetraazacyclohexadecane
3,3'-bis-1,5,8,11,14-pentaazacyclohexadecane
5,5'-bis-1,4,8,11-tetraazacyclotetradecane
2,5'-bis-1,4,8,11-tetraazacyclotetradecane
2 The grandparent of this application, Application No. 07/454,418, has become
U.S. Patent No. 5,021,409, with claims directed to a method of treating infection by a
retrovirus.
2
Page: Previous 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 Next
Last modified: November 3, 2007